CTTH Ctt Pharmaceutical Holdings, Inc.

Fundamentals / CIK 0001035422 / USD

Ctt Pharmaceutical Holdings, Inc. reported $78K in total assets and a net loss of $672K through December 31, 2014 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CTTH in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2010 to 2014), reported in USD.

$3.80M$1.90M$0-$1.34MFY 2010 Net Income: -$1.10M2010FY 2011 Net Income: $3.74M2011FY 2012 Net Income: -$1.00M2012FY 2013 Net Income: -$19K2013FY 2014 Net Income: -$672K2014

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Total Operating Expenses $672K $19K $1.19M $758K $2.07M
Operating Income -$672K -$19K -$1.19M -$758K -$2.07M
EBITDA -- -- -- -$758K -$2.00M
Net Income -$672K -$19K -$1.00M $3.74M -$1.10M
Basic EPS $0.01 $0.01 -$0.11 $0.42 -$0.13
Diluted EPS $0.01 $0.01 -$0.11 $0.40 -$0.13
Basic Shares Outstanding 163.4M 9.4M 9.4M 8.9M 8.5M
Diluted Shares Outstanding 163.4M 9.4M 9.4M 9.5M 8.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2025-09-30 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30
Total Operating Expenses $127K $15K $342K $363K $337K $629K $43K $920
Operating Income -- -- -- -- -$337K -- -- -$22K
Interest Income $131 $0 -- -- -- -- -- --
Net Income -$127K -$15K -$342K -$363K -$337K -$629K -$43K -$920
Basic EPS -- -- -$0.03 $0.00 $0.02 -- $0.01 $0.00
Diluted EPS $0.00 $0.00 -$0.03 $0.00 $0.02 -- -$0.01 $0.00
Basic Shares Outstanding 60.7M 57.3M 21.3M 213.2M 195.1M -- 15.8M 22.3M
Diluted Shares Outstanding 60.7M 57.3M 21.3M 213.2M 195.1M -- 15.8M 22.3M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $81K $0 $0 $569K $46K
Short-Term Investments -- $0 $164K $0 --
Cash & Short-Term Investments $81K $0 $164K $569K $46K
Accounts Receivable, Net $5.4K $0 $8.7K $151 $166K
Total Current Assets $1.05M $6.3K $203K $751K $520K
Property, Plant & Equipment, Net -- -- -- $0 $426K
Total Non-Current Assets $613K -$6.3K $0 $3.43M $743K
Total Assets $1.66M $0 $203K $4.18M $1.26M
Total Current Liabilities -- $249K $589K $3.73M $945K
Total Non-Current Liabilities -- -$220K $0 $0 $316K
Total Liabilities $169K $29K $589K $3.73M $1.26M
Common Stock $2.0K $15K $19K $19K $18K
Retained Earnings -$867K -$195K -- -- --
Accumulated Other Comp. Income -$1.1K -$4.2K $5.0K -$106K -$106K
Total Stockholders' Equity $1.49M -$29K -$20K $456K $1.3K
Total Equity $1.49M -$29K -$20K $456K $1.3K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2025-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30
Cash & Cash Equivalents -- -- -- $32K $46K $73K $81K $125K
Cash & Short-Term Investments -- -- -- $32K $46K $73K $81K $125K
Accounts Receivable, Net -- -- -- $5.4K $5.4K $5.4K $5.4K $5.4K
Total Current Assets $13K $31 $15K $922K $959K $1.04M $1.05M --
Intangible Assets $66K $67K $71K -- -- -- -- --
Total Non-Current Assets $66K $67K $71K $0 $225K $377K $613K --
Total Assets $78K $67K $86K $922K $1.18M $1.42M $1.66M $131K
Total Current Liabilities $37K $41K $31K -- -- -- -- --
Total Non-Current Liabilities $0 $0 $0 -- -- -- -- --
Total Liabilities $37K $41K $31K $184K $196K $1.12M $169K $125K
Common Stock $6.2K $6.0K $5.9K $2.1K $21K $20K $2.0K $18K
Retained Earnings -$7.78M -$7.65M -$7.55M -$1.91M -$667K -$304K -$867K -$231K
Accumulated Other Comp. Income -- -- -- $3.8K $1.3K $2.3K -$1.1K -$3.1K
Total Stockholders' Equity $41K $26K $55K $738K $987K $301K $1.49M $6.1K
Total Equity $41K $26K $55K $738K $987K $301K $1.49M $6.1K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$672K -$19K -$1.00M $3.74M -$1.10M
Depreciation & Amortization -- -- -- $0 $70K
Stock-Based Compensation $308K $0 $42K $155K $154K
Change in Receivables -- $3.3K -$8.6K $0 -$158K
Operating Cash Flow -$72K -$209 -$1.03M -$316K -$1.67M
Investing Cash Flow $152K $125K $436K $877K $0
Common Stock Issued -- -- -- $0 $1.80M
Financing Cash Flow -- $0 $34K -$38K $1.45M
Net Change in Cash $81K -$11K -$557K $523K -$225K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2025-09-30 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30
Net Income -$127K -$15K -$342K -$363K -$337K -$629K -$43K -$920
Stock-Based Compensation -- -- $46K $49K $44K -- -- --
Change in Receivables -- -- -- -- -- -- -- $0
Operating Cash Flow -- -- -$16K -$29K -$40K -$47K -$24K -$29K
Investing Cash Flow -- -- -- -- -- -$1 $271K -$148K
Financing Cash Flow -- -- -$959 $2.8K $29K -- -$4.9K $387K
Net Change in Cash -- -- -$14K -$27K -$7.7K -$44K $122K $210K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -45.0% -- -- 819.0% -81554.2%
Return on Assets (ROA) -40.4% -- -494.0% 89.4% -87.0%
Current Ratio -- 0.03x 0.34x 0.20x 0.55x
Quick Ratio -- 0.00x 0.29x 0.15x 0.22x
Net Income Growth (YoY) -- -- -126.8% -- --
EPS Growth (YoY) 0.0% -- -126.2% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2025-09-30 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30
Return on Equity (ROE) -- -- -226.3% -139.0% -335.6% -45.2% -866.6% -21.7%
Return on Assets (ROA) -- -- -181.1% -115.9% -71.2% -40.6% -40.7% -8.2%
Current Ratio 0.34x -- -- -- -- -- -- --
EPS Growth (YoY) -- -- -400.0% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001035422) · from June 30, 2010 Data through September 30, 2026 · synced Nov 21, 2026, 05:10 UTC · Open in terminal